Literature DB >> 12882779

Serum albumin in mammalian cornea: implications for clinical application.

David W Nees1, Robert N Fariss, Joram Piatigorsky.   

Abstract

PURPOSE: To compare the abundance and spatial distribution of serum albumin in the mouse and bovine cornea.
METHODS: Serum albumin from cornea was separated from transketolase by SDS-PAGE (+/-dithiothreitol [DTT]) and identified by peptide sequencing and immunoblot analyses. The fractional content of serum albumin was determined in water-soluble extracts of cornea by imaging analyses after SDS-PAGE. Serum albumin was localized in cornea by immunohistochemistry and by SDS-PAGE analyses of samples from separated epithelium and stroma.
RESULTS: SDS-PAGE (-DTT) resolved mouse serum albumin and transketolase and indicated that serum albumin was 13% of the water-soluble protein in whole mouse corneas. By contrast, corneal epithelial fractions contained little (<1%) serum albumin. Immunohistochemistry indicated that mouse serum albumin was present throughout the stroma between collagen lamellae. Immunohistochemical analyses of bovine cornea yielded similar results. In addition, immunohistochemistry for serum albumin revealed positive staining in a small number of basal epithelial cells next to Bowman's membrane, and greater staining in the anterior-peripheral stroma as well as immediately adjacent to Descemet's membrane.
CONCLUSIONS: Mouse and bovine cornea have a similar content and spatial distribution of serum albumin. The appreciable serum albumin in the cornea documented here and elsewhere raise the possibility that it contributes to the physiological or optical functions of the cornea. Moreover, serum albumin's ability to bind drugs suggests that mice corneas could be exploited to study drug-serum albumin interactions in vivo and to test the usefulness of serum albumin as a drug carrier for corneal disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882779     DOI: 10.1167/iovs.02-1161

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

Review 1.  Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes.

Authors:  Satori A Marchitti; Ying Chen; David C Thompson; Vasilis Vasiliou
Journal:  Eye Contact Lens       Date:  2011-07       Impact factor: 2.018

Review 2.  Conjunctival goblet cells: Ocular surface functions, disorders that affect them, and the potential for their regeneration.

Authors:  Shivalingappa K Swamynathan; Alan Wells
Journal:  Ocul Surf       Date:  2019-11-14       Impact factor: 5.033

3.  Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.

Authors:  Purva Khare; Manasi M Chogale; Pratik Kakade; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2022-05-10       Impact factor: 5.671

4.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 5.  Antioxidant defenses in the ocular surface.

Authors:  Ying Chen; Gaurav Mehta; Vasilis Vasiliou
Journal:  Ocul Surf       Date:  2009-10       Impact factor: 5.033

6.  Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice.

Authors:  Natalie Lassen; J Bronwyn Bateman; Tia Estey; Jer R Kuszak; David W Nees; Joram Piatigorsky; Gregg Duester; Brian J Day; Jie Huang; Lisa M Hines; Vasilis Vasiliou
Journal:  J Biol Chem       Date:  2007-06-13       Impact factor: 5.157

7.  Identification of Important Genes of Keratoconus and Construction of the Diagnostic Model.

Authors:  Lin Wang; Yuqing Wang; Juan Liu; Wencheng Zhao
Journal:  Genet Res (Camb)       Date:  2022-09-12       Impact factor: 1.375

8.  Anterior segment dysgenesis after overexpression of transforming growth factor-beta-induced gene, beta igh3, in the mouse eye.

Authors:  Jung-Eun Kim; Min-Su Han; Yong-Chul Bae; Hong-Kyun Kim; Tae-Im Kim; Eung Kweon Kim; In-San Kim
Journal:  Mol Vis       Date:  2007-10-16       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.